Does the imprecise definition of overactive bladder serve commercial rather than patient interests?

European Urology

Volumn 61, Issue 4, 2012, Pages 746-748

  Tikkinen, Kari A O ^a,b   Auvinen, Anssi ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MCMASTER UNIVERSITY   (Canada)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER INSTABILITY; BLADDER IRRITATION; CLINICAL STUDY; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; FUNDING; HUMAN; MARKETING; NOMENCLATURE; OVERACTIVE BLADDER; PRIORITY JOURNAL; REVIEW; SYMPTOM; TREATMENT INDICATION; URINARY URGENCY;

EID: 84857649515     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.12.013     Document Type: Editorial

References (15)

1. M. Fall, B.L. Ohlsson, and C.A. Carlsson The neurogenic overactive bladder. Classification based on urodynamics Br J Urol 64 1989 368 373 (Pubitemid 19252924)
2. P. Abrams, and A.J. Wein The overactive bladder: from basic science to clinical management Urology 50 Suppl 1997 1 3 (Pubitemid 28027838)
3. P. Abrams, L. Cardozo, and M. Fall The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178 (Pubitemid 34195211)
4. K.A. Tikkinen, T.L. Tammela, A.M. Rissanen, A. Valpas, H. Huhtala, and A. Auvinen Is the prevalence of overactive bladder overestimated? A population-based study in Finland PLoS One 2 2007 e195
5. J.G. Ouslander Management of overactive bladder N Engl J Med 350 2004 786 799 (Pubitemid 38209648)
6. H. Madersbacher Overactive bladder: a clinical entity or a marketing hype? Eur Urol 47 2005 273 276 (Pubitemid 40248842)
7. Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep) 2009; 187:1-120, v.
8. R. Moynihan, I. Heath, and D. Henry Selling sickness: the pharmaceutical industry and disease mongering BMJ 324 2002 886 891
9. J. Lexchin, L.A. Bero, B. Djulbegovic, and O. Clark Pharmaceutical industry sponsorship and research outcome and quality: systematic review BMJ 326 2003 1167 1170 (Pubitemid 36649048)
10. C.P. Vaughan, T.M. Johnson II, and M.A. Ala-Lipasti The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study Eur Urol 59 2011 629 636
11. D.E. Irwin, Z.S. Kopp, B. Agatep, I. Milsom, and P. Abrams Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction BJU Int 108 2011 1132 1138
12. D.E. Irwin, I. Milsom, and S. Hunskaar Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 2006 1306 1315 (Pubitemid 44692945)
13. S. Herschorn Overactive bladder: symptom complex or separate entity? Can Urol Assoc J 5 Suppl 2 2011 S152 S154
14. J.M. Pearce Disease, diagnosis or syndrome? Pract Neurol 11 2011 91 97
15. P. Abrams Nocturia: escaping the "prostate-centric" approach J Urol 185 2011 781 782